Protein A Resins Market : Key Players, Applications, Outlook, SWOT Analysis And Forecasts 2022 to 2030
The global protein A resins market is valued at US$ 536.6 Mn in 2020 and is expected to surpass US$ 1.2 Bn by 2031, registering a CAGR of 8.1% over the forecast period (2021-2031) according to Future Market Insights (FMI) study.
Future Market Insights' recent report on the protein a-resins market concludes
that the market is anticipated to witness robust growth across the upcoming
decade's forecast period.
Growing investments in synthetic biology is accelerating adoption of
protein engineered products in order to manufacture protein infused drugs and
formulations. A significant advancement has been noticed in the field of
monoclonal antibodies (mAbs) which are used to treat a host of chronic and
infectious diseases. Protein A-resins are exhaustively utilized for the
purification of mAbs, a key driver enhancing the growth prospects for the
upcoming forecast period.
Significant growth acceleration in the protein a-resins market was
witnessed when GE Healthcare launched its MabSelect PrismA chromatography resin
in 2017. Designed to purify bispecific antibodies (BsAbs) in a single step,
protein a-chromatography has provided 90% purity levels. The resin makes effective
usage of Protein-A ligand and a novel agarose bead to achieve dynamic binding
capacities.
On a similar plane, MIT chemists have devised an automated
flow synthesis machine which significantly reduces the time required for
synthetic protein generation. The enhanced capacity of the machine allows for
greater loading of multiple amino acids within a span of few hours. This
automation is anticipated to attract investors, providing a stimulus to the
market during the forecast period.
Request a Sample Report with Table of Contents and Figures @
https://www.futuremarketinsights.com/reports/sample/rep-gb-1720
"Credible research is being undertaken with regard to monoclonal
antibodies to ascertain its possible application areas, prompting an increase
in protein A-resins usage, anticipated to register positive year-on-year growth
with manufacturers focusing on technological advancements," according to
an FMI analyst.
Key Takeaways from FMI's Protein A-Resins Market Report
- Protein
A-Resins market shall expand at a CAGR of 8.2% throughout 2020
- Natural
protein A-resins shall account for the maximum share of revenue throughout
the forecast period
- By
application, the antibody purification segment accounted for the maximum
share in 2019 and is anticipated to retain the same during the forecast
period
- Agarose-based
matrix is the most prominent medium utilized in the protein A-resins
market
- Biopharmaceutical
manufacturers make extensive usage of protein a-resins due to extensive
applications in manufacturing protein-based drugs
- North
America shall emerge as a leader in the protein a-resins market,
with the United States contributing 70% of the revenue pie
Protein A-Resins Market- Key Trends
- Demand
for purification of antibodies is especially strong in the immunotherapy
segment. For instance, the US FDA has approved immunotherapy to treat CD19
positive hematological cancers
- Also,
protein A-chromatography is useful for purifying FGFR4 which is marked in
CAR-T therapy by chimeric antigen receptors
- Mixed-mode
chromatography is providing fertile ground for biomolecule purification
which otherwise are extremely difficult to purify using conventional
chromatography techniques. Improved yield, immense room for facilitating
protein interaction and minimal feed manipulation before binding are the
advantages accelerating their usage
Protein-A Resins Market- Region-wise Analysis
- Asia
Pacific is emerging as a promising growth avenue during the forecast
period. Rising demand for immunotherapy drugs to treat chronic ailments is
expected to elevate the regional market to a higher pedestal
- Uptake
of protein A-resins in the Latin American and European markets is
increasing. Rising investments in protein-based research is attracting
market players to establish their businesses across these regions
- Massive
clinical trials in the field of synthetic biologics and monoclonal
antibodies is expected to increase uptake of protein A-resins across the
North American market
Request special price for this report to our sales executive @
https://www.futuremarketinsights.com/request-special-price/rep-gb-1720
Protein-A Resins Market- Competitive Landscape
The protein A-resins market is characterized by constant innovations and
product approvals in the bio therapeutics domain, which provides them with a
competitive edge over each other. Market players are constantly launching new
products to cater to cardiovascular ailments, immune therapy, cancer and
microbial infections.
In May 2020, Avantor doled out its new protein A-chromatography
resin titled PROchievA which uses a novel, proprietary ligand to provide the
best in-class purification in critical protein A-chromatography steps of
monoclonal antibodies manufacturing. The product demonstrates excellent dynamic
binding capacities compared to other resins on the market.
Also, Novasep produces the AbSoulte High Cap Protein A-Media, an
optimized silica-based medium for the capture of monoclonal and polyclonal
antibodies. This media is well-adapted to all fermentation volumes while
offering the highest dynamic and static binding capacities and subsequently
high productivity at increased velocities.
Protein A Resins Market Taxonomy
Product Type
- Natural
Protein A Resin
- Recombinant
Protein A Resin
Matrix Type
- Agarose
Based Matrix
- Glass
or Silica Based
- Organic
Polymer Based
Application
- Immunoprecipitation
- Antibody
Purification
End-User
- Hospitals
- Ambulatory
Surgical Centers
- Catheterization
Laboratories
Full Report @ https://www.futuremarketinsights.com/reports/protein-a-resins-market
Comments
Post a Comment